Search

everythinglearnresearchcommunity

for

Search:↓

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Skin problems are common and important signs of eating disorders and treating the eating disorder can improve these skin conditions.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Distinct β-catenin patterns are linked to cell growth, not cell death, in lung cancer.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Androgens may block hair growth signals, targeting this could treat hair loss.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Melatonin solution helps treat hair loss in men and women.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.